Graves Hyperthyroidism1 |
Radioiodine and prednisone vs. radioiodine therapy |
Development and improvement of opthalmopathy |
1 year |
15 |
0 |
7 (5 to 11) |
Type 2 diabetes mellitus in overweight patients2 |
Radioiodine and prednisone vs. radioiodine therapy |
Diabetes related end point |
10 years |
39 |
29 |
10 (6 to 29) |
Deaths from diabetes |
|
13 |
8> |
19 (10 to 138) |
All cause mortality |
|
22 |
15 |
14 (8 to 67) |
MI |
|
18 |
11 |
16 (9 to 78) |
Diabetic men with erectile dysfunction3 |
Sildenafil vs. placebo |
Improved erections |
12 weeks |
10.2 |
56.5 |
3 (2 to 3) |
“Insulin requiring” diabetes4 |
Regular telephone contact with a diabetes nurse educator for advice about adjustment of insulin therapy vs. regular clinic visits and usual contact with the endocrinologist for insulin adjustment |
Mean HbAlc level and proportion of patients who achieved a reduction in HbAlc level ≥ 10% |
6 months |
35 |
87 |
2 (1 to 4) |